Waldencast

Waldencast company information, Employees & Contact Information

Explore related pages

Related company profiles:

Waldencast is a holding company and investment fund that incubates and accelerates early stage beauty and wellness brands and helps them rapidly create scale and profitability via industry specific operational expertise. Waldencast invests in brand-led business models and goes beyond traditional incubation and acceleration to develop a collective of innovative and unique brands that place responsible entrepreneurship at the heart of its operations. Waldencast has offices in New York and London and has an investment portfolio in North America, Europe, and Latin America. The selection of brands to participate in the community is as much driven by the strength of the brand concept and business model as it is by our shared human and social values: sustainability, responsibility, inclusivity. We believe brands that marry purpose, art, beauty, and design with industry and commerce to make the planet and the lives of those in it better. Individuals that are part of the Waldencast collective are as much driven by the strength of the brands’ ideas, as it is by sharing our dreamer/maker values: ambition with humility, idealism with practicality, grit with empathy, vision with action. We have the spirit of a challenger, a disruptor, a game-changer. We are a start-up and we intend to stay in the attitude of a start-up regardless of our success.

Company Details

Employees
65
Address
New York, Ny 10014, Us
Email
co****@****ast.com
Industry
Personal Care Product Manufacturing
NAICS
Toilet Preparation Manufacturing
HQ
New York, NY
Looking for a particular Waldencast employee's phone or email?

Waldencast Questions

News

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum - GlobeNewswire

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum GlobeNewswire

Waldencast Doubles Market Reach to $4.2B Through Major Aesthetics Acquisition and Injectable Product Rights - Stock Titan

Waldencast Doubles Market Reach to $4.2B Through Major Aesthetics Acquisition and Injectable Product Rights Stock Titan

Waldencast Acquires Novaestiq Corp, Expanding Obagi Medical's Injectable Product Portfolio and Market Reach - Nasdaq

Waldencast Acquires Novaestiq Corp, Expanding Obagi Medical's Injectable Product Portfolio and Market Reach Nasdaq

Waldencast plc Receives FDA Approval for Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel, Entering U.S. Dermal Filler Market - Quiver Quantitative

Waldencast plc Receives FDA Approval for Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel, Entering U.S. Dermal Filler Market Quiver Quantitative

Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the United States - PR Newswire

Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the United States PR Newswire

Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast - Infosalus

Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast Infosalus

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation - The Manila Times

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation The Manila Times

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream - Nasdaq

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream Nasdaq

Milk Makeup Owner Waldencast Postpones Earnings and Cuts Forecast, Will Undertake Strategic Review - The Business of Fashion

Milk Makeup Owner Waldencast Postpones Earnings and Cuts Forecast, Will Undertake Strategic Review The Business of Fashion

Waldencast Acquires Novaestiq and US Rights to Saypha - BeautyMatter

Waldencast Acquires Novaestiq and US Rights to Saypha BeautyMatter

Waldencast: Fairly Valued With Ulta Lift Already Reflected, Saypha Deal Adds Optionality - Seeking Alpha

Waldencast: Fairly Valued With Ulta Lift Already Reflected, Saypha Deal Adds Optionality Seeking Alpha

Earnings call transcript: Waldencast Q1 2025 sees stock dip after earnings miss - Investing.com

Earnings call transcript: Waldencast Q1 2025 sees stock dip after earnings miss Investing.com

Waldencast Reports H1 2025 Brand Growth, Acquires Novaestiq, and Reviews Strategic Options - Global Cosmetics News

Waldencast Reports H1 2025 Brand Growth, Acquires Novaestiq, and Reviews Strategic Options Global Cosmetics News

Waldencast: Learning To Grow Hurts Sometimes (NASDAQ:WALD) - Seeking Alpha

Waldencast: Learning To Grow Hurts Sometimes (NASDAQ:WALD) Seeking Alpha

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection - GlobeNewswire

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection GlobeNewswire

Waldencast Names Manuel Manfredi as CFO - citybiz

Waldencast Names Manuel Manfredi as CFO citybiz

Milk Makeup Extends Its Roots in Music and Culture - PR Newswire

Milk Makeup Extends Its Roots in Music and Culture PR Newswire

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum to Address Hair Thinning and Scalp Health - Quiver Quantitative

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum to Address Hair Thinning and Scalp Health Quiver Quantitative

Waldencast Expands Global Beauty Footprint With Middle East Hub - WWD

Waldencast Expands Global Beauty Footprint With Middle East Hub WWD

Waldencast Delays Earnings Release, Initiates Strategic Review Following Novaestiq Acquisition - WWD

Waldencast Delays Earnings Release, Initiates Strategic Review Following Novaestiq Acquisition WWD

Obagi Medical Expands Into Fillers Following FDA Approval - Dermatology Times

Obagi Medical Expands Into Fillers Following FDA Approval Dermatology Times

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Benzinga

Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & - GlobeNewswire

Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & GlobeNewswire

74% Reduction in Dry Fallen Hair — Obagi Medical’s Nu-Cil BioStim Scalp Serum launches at $125, clinically proven - Stock Titan

74% Reduction in Dry Fallen Hair — Obagi Medical’s Nu-Cil BioStim Scalp Serum launches at $125, clinically proven Stock Titan

Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc. - GlobeNewswire

Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc. GlobeNewswire

Milk Makeup to Launch at Ulta Beauty This Spring - PR Newswire

Milk Makeup to Launch at Ulta Beauty This Spring PR Newswire

Waldencast Announces $1.2 Billion Three-Way Business Combination with Obagi and Milk Makeup as a First Step in its Strategy to Create a Global Multi-Brand Beauty and Wellness Platform - Business Wire

Waldencast Announces $1.2 Billion Three-Way Business Combination with Obagi and Milk Makeup as a First Step in its Strategy to Create a Global Multi-Brand Beauty and Wellness Platform Business Wire

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream - GlobeNewswire

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream GlobeNewswire

Waldencast Acquisition Corporation Goes Public via SPAC - The Business of Fashion

Waldencast Acquisition Corporation Goes Public via SPAC The Business of Fashion

MILK MAKEUP ANNOUNCES NILOFER VAHORA AS CMO - PR Newswire

MILK MAKEUP ANNOUNCES NILOFER VAHORA AS CMO PR Newswire

WALD Stock Price and Chart — NASDAQ:WALD - TradingView

WALD Stock Price and Chart — NASDAQ:WALD TradingView

Top Waldencast Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant